This inventor holds 2 USPTO granted patents. Top assignee: University of Arkansas. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2005
Title: Richard A Marlar: Innovator in Ophthalmologic Applications
Introduction
Richard A Marlar is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of ophthalmology, particularly through his innovative methods involving Protein C. With a total of 2 patents, Marlar's work focuses on reducing intraocular fibrin and addressing various intraocular diseases.
Latest Patents
Marlar's latest patents include groundbreaking methods for reducing intraocular fibrin. The first patent outlines a method that involves administering a pharmacologically effective dose of Protein C to individuals with elevated levels of intraocular fibrin. This invention not only aims to reduce intraocular fibrin formation but also provides various methods for treating intraocular diseases and reducing inflammation. The second patent reiterates these innovative approaches, emphasizing the importance of Protein C in ophthalmologic applications.
Career Highlights
Richard A Marlar is affiliated with the University of Arkansas, where he continues to advance research in ophthalmology. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from intraocular conditions. Marlar's dedication to innovation in this field is evident through his successful patent applications.
Collaborations
Some of Marlar's notable coworkers include Louis M Fink and Thomas L Steinemann. Their collaborative efforts contribute to the ongoing research and development in ophthalmologic applications.
Conclusion
Richard A Marlar stands out as an influential inventor in the realm of ophthalmology, with his innovative methods and patents paving the way for advancements in treating intraocular diseases. His contributions are vital to improving patient care and outcomes in this specialized field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
